But the company's relationships with drug companies have drawn increasing scrutiny.
A panel of South Carolina legislators has advanced a resolution urging Congress to open more research on medical uses for marijuana. The measure approved Thursday now goes to the full
Money often spent while companies had drugs ‘under review for public reimbursement’ through PBS
Major pharmaceutical companies injected more than $34m into patient advocacy groups in four years, often at the same time as they lobbied for related drugs to be listed on the pharmaceutical benefits scheme, new research suggests.
A study published by University of Sydney’s Charles Perkins Centre on Wednesday has for the first time mapped the links between big pharmaceutical players and consumer...